- Thermo Fisher Scientific (TMO) Q3 results: Revenues: $6,272M (+5.9%); Life Sciences Solutions: $1,701M (+13.1%); Analytical Instruments: $1,358M (+1.9%); Specialty Diagnostics: $879M (-1.7%); Laboratory Products and Services: $2,619M (+6.0%).
- Net Income: $760M (+7.2%); EPS: $1.88 (+7.4%); non-GAAP Net Income: $1,187M (+11.4%); non-GAAP EPS: $2.94 (+12.2%); CF Ops: $3,060M (+11.6%).
- 2019 Guidance: Revenue: $25.34B - 25.50B from $25.30B - $25.50B; Non-GAAP EPS: $12.28 - 12.34 from $12.16 - 12.26.
- Previously: Thermo Fisher Scientific EPS beats by $0.05, beats on revenue (Oct. 23)
Thermo Fisher beats Q3 consensus; guidance raised
Recommended For You
About TMO Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
TMO | - | - |
Thermo Fisher Scientific Inc. |